whereas mild disease was 16.5%. Mean duration of follow up was 41±19 months. For every 1- month increase in duration of follow up, the odds of remission increase by 6% (CI: 1.04-1.09, P<0.05).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback